查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132435

藥物穩定性和保存服務市場規模、佔有率和趨勢分析報告：按服務、分子、地區和細分市場預測（2026-2033 年）

Pharmaceutical Stability and Storage Services Market Size, Share & Trends Analysis Report By Service, By Molecule, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 0.065 Pages | 商品交期: 2-10個工作天內

價格

藥品穩定性和儲存服務市場概述

全球藥品穩定性和儲存服務市場預計到 2025 年將達到 20 億美元，到 2026 年將成長到 22 億美元，到 2033 年將達到 34 億美元，2026 年至 2033 年的複合年成長率為 6.5%。

預計到2025年，北美市場將成為市場成長的主要驅動力，佔全球銷售額的40.1%。市場成長的促進因素包括藥物開發平臺的擴展、生物製藥和先進療法產量的增加，以及驗證保存期限和儲存條件的強制性監管要求。

其他促進市場成長的因素包括製藥和生物技術公司外包業務的增加、活性化的臨床試驗、對低溫和超低溫儲存的需求不斷成長、常規的商業穩定性測試計劃、包裝和配方的變化，以及採用數位監控和符合合規要求的樣品管理系統。

全球藥品穩定性和儲存服務市場報告

本報告預測了2021年至2033年全球、區域和各國的銷售成長情況，並分析了各細分市場的最新產業趨勢。在本研究中，Grand View Research根據服務、分子和地區對全球藥物穩定性和儲存服務市場報告進行了細分。

  • 特定服務展望（收入，2021-2033 年）。
  • 穩定。
    • 原料藥。
    • 穩定性評估方法的驗證。
    • 加速穩定性測試
    • 光照穩定性測試
    • 其他穩定性測試方法
  • 保持
    • 冷藏
    • 室溫
  • 數值預測（收入，百萬美元，2021-2033 年）。
  • 低分子
    • 研究產品
    • 市售產品
  • 聚合物
    • 研究產品
    • 市售產品
  • 區域預測（收入，百萬美元，2021-2033 年）。
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

目錄

第1章 研究方法和範圍

第2章執行摘要

第3章：藥品穩定性與保藏服務市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 基於經營模式的分析
  • 科技情勢
  • 定價模式分析
  • 分析關稅和貿易協定的影響
  • 產業特定生態系分析
  • 市場分析工具

第4章：藥品穩定性與保藏服務市場：依服務類型分類的估算與趨勢分析

  • 藥品穩定性與保藏服務市場：按服務類型分類的趨勢分析
  • 藥品穩定性與保存服務市場：按服務類型分類的估算與預測，2021-2033年
  • 穩定
    • 原料藥
    • 穩定性評估方法的驗證
    • 加速穩定性測試
    • 光照穩定性測試
    • 其他穩定性測試方法
  • 貯存
    • 冷藏
    • 無需冷藏

第5章：藥物穩定性與保存服務市場：按分子分類的估算與趨勢分析

  • 藥物穩定性與保存服務市場：按分子類型分類的趨勢分析
  • 藥物穩定性和保存服務市場：按分子分類的估計和預測，2021-2033年
  • 低分子
    • 研究產品
    • 市售產品
  • 聚合物
    • 研究產品
    • 市售產品

第6章：藥品穩定性與保藏服務市場：區域估算與趨勢分析

  • 區域市場概覽
  • 2025年及2033年區域市佔率分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • UAE
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第7章 競爭情勢

  • 主要公司分類
    • Market Leaders
    • Emerging Players
  • 2025年市場估值分析（熱圖分析）
  • 公司簡介
    • Catalent, Inc
    • Almac Group
    • Charles River Laboratories
    • Eurofins Scientific
    • Intertek Group plc
    • Lucideon Limited
    • Alcami Corporation
    • Element Materials Technology
    • BioLife Solutions Inc.
    • Q1 Scientific
    • Reading Scientific Services Ltd.
    • Roylance Stability Storage Limited
    • ALS
    • Q Laboratories
    • Auriga Research Private Limited
    • PD Partners
    • Precision Stability Storage
    • SGS Societe Generale de Surveillance SA.
Product Code: GVR-4-68039-936-6

Pharmaceutical Stability And Storage Services Market Summary

The global pharmaceutical stability and storage services market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 3.4 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The market in North America dominated with a revenue share of 40.1% in 2025. Market growth is driven by expanding drug development pipelines, increasing production of biologics & advanced therapies, and mandatory regulatory requirements for shelf-life and storage validation.

Other factors contributing to market growth include rising outsourcing by pharmaceutical and biotechnology companies, increasing clinical trial activity, greater demand for cold- and ultra-low-temperature storage, recurring commercial stability programs, packaging and formulation changes, and the adoption of digital monitoring and compliant sample-management systems.

Global Pharmaceutical Stability And Storage Services Market Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical stability and storage services market report based on service, molecule, and region.

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Stability
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Other Stability Testing Methods
  • Storage
    • Cold
    • Non-cold
  • Molecule Outlook (Revenue, USD Million, 2021 - 2033)
  • Small Molecule
    • Research Products
    • Commercial Products
  • Large Molecule
    • Research Products
    • Commercial Products
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Molecule
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Bottom-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Stability and Storage Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. High R&D Spending of Pharmaceutical & Biotechnology Companies
      • 3.2.1.2. Rising Demand for Outsourcing Stability Testing Due to High Complexity Associated with Drug Stability
      • 3.2.1.3. Growing Demand for Biosimilars
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Strict Regulations for Global Pharmaceutical Stability and Storage Services Drugs
      • 3.2.2.2. Issues Associated with Stability Chambers
  • 3.3. Business Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Pricing Model Analysis
  • 3.6. Tariff and Trade Agreement Impact Analysis
  • 3.7. Industry Ecosystem Analysis
  • 3.8. Market Analysis Tools
    • 3.8.1. Porter's Five Force Analysis
    • 3.8.2. PESTEL by SWOT Analysis

Chapter 4. Pharmaceutical Stability and Storage Services Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Stability and Storage Services Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Stability and Storage Services Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Stability
    • 4.4.1. Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Drug Substance
      • 4.4.2.1. Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Stability Indicating Method Validation
      • 4.4.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Accelerated Stability Testing
      • 4.4.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Photostability Testing
      • 4.4.5.1. Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.6. Other Stability Testing Methods
      • 4.4.6.1. Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Storage
    • 4.5.1. Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Cold
      • 4.5.2.1. Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Non-Cold
      • 4.5.3.1. Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Pharmaceutical Stability and Storage Services Market: Molecule Estimates & Trend Analysis

  • 5.1. Pharmaceutical Stability and Storage Services Market, By Molecule: Segment Dashboard
  • 5.2. Pharmaceutical Stability and Storage Services Market, By Molecule: Movement Analysis
  • 5.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Molecule, 2021 - 2033 (USD Million)
  • 5.4. Small Molecule
    • 5.4.1. Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.2. Research Products
      • 5.4.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.4.3. Commercial Products
      • 5.4.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Large Molecule
    • 5.5.1. Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.2. Research Products
      • 5.5.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5.3. Commercial Products
      • 5.5.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Pharmaceutical Stability and Storage Services Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2025 & 2033
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. Japan
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Thailand
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.4. Saudi Arabia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.6. Qatar
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.7. Oman
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Key Participant Categorization
    • 7.1.1. Market Leaders
    • 7.1.2. Emerging Players
  • 7.2. Market Assessment Analysis, 2025 (Heat Map Analysis)
  • 7.3. Company Profiles
    • 7.3.1. Catalent, Inc
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Almac Group
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Charles River Laboratories
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Eurofins Scientific
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Intertek Group plc
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Lucideon Limited
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Alcami Corporation
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. Element Materials Technology
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. BioLife Solutions Inc.
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. Q1 Scientific
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Reading Scientific Services Ltd.
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Roylance Stability Storage Limited
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. ALS
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Q Laboratories
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. Auriga Research Private Limited
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. PD Partners
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Service Benchmarking
      • 7.3.16.4. Strategic Initiatives
    • 7.3.17. Precision Stability Storage
      • 7.3.17.1. Company Overview
      • 7.3.17.2. Financial Performance
      • 7.3.17.3. Service Benchmarking
      • 7.3.17.4. Strategic Initiatives
    • 7.3.18. SGS Societe Generale de Surveillance SA.
      • 7.3.18.1. Company Overview
      • 7.3.18.2. Financial Performance
      • 7.3.18.3. Service Benchmarking
      • 7.3.18.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 5 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 6 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 7 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 8 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 9 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 10 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 12 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 13 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 14 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 15 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 16 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 17 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 18 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 19 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 20 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 21 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 22 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 23 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 25 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 26 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 27 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 28 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 29 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 31 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 32 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 33 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 34 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 35 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 36 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 37 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 38 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 40 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 41 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 42 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 43 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 44 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 46 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 47 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 48 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 49 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 50 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 51 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 52 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 53 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 54 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 55 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 56 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 57 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 59 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 60 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 62 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 63 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 64 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 65 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)
  • Table 66 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2025 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2025 (USD Billion)
  • Fig. 16 Pharmaceutical Stability and Storage Services Market Dynamics
  • Fig. 17 Porter's Five Forces Analysis
  • Fig. 18 PESTEL Analysis
  • Fig. 19 Pharmaceutical Stability and Storage Services Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Stability and Storage Services Market: Service movement analysis
  • Fig. 21 Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Pharmaceutical Stability and Storage Services Market: Molecule outlook and key takeaways
  • Fig. 31 Pharmaceutical Stability and Storage Services Market: Molecule movement analysis
  • Fig. 32 Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Regional Marketplace: Key Takeaways
  • Fig. 39 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021-2033 (USD Million)
  • Fig. 40 Key Country Dynamics
  • Fig. 41 U.S. Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Key Country Dynamics
  • Fig. 43 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Key Country Dynamics
  • Fig. 45 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key Country Dynamics
  • Fig. 50 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key Country Dynamics
  • Fig. 52 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 Key Country Dynamics
  • Fig. 78 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Key Country Dynamics
  • Fig. 80 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 MEA Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key Country Dynamics
  • Fig. 83 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key Country Dynamics
  • Fig. 85 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key Country Dynamics
  • Fig. 87 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)